Delayed Hypersensitivity with Ferric Carboxymaltose

Delayed Hypersensitivity with Ferric Carboxymaltose

Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and th...

Full description

Bibliographic Details
Main Authors: Surabhi Sridhara, Rajesh Vilakkathala, Ravindra Prabhu, Karan Saraf
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-11-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Anaemia
Hypersensitivity
Iron preparations
Online Access:http://jcdr.net/articles/PDF/10827/25908-CE(RA1)_F(GG)_PF1(PB_AP)_PFA(MJ_SS).pdf
id doaj-bbef449967674c9c9f41bc759fa87d98
record_format Article
spelling doaj-bbef449967674c9c9f41bc759fa87d982020-11-25T00:20:55ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2017-11-011111FD01FD0210.7860/JCDR/2017/25908.10827Delayed Hypersensitivity with Ferric CarboxymaltoseSurabhi Sridhara0Rajesh Vilakkathala1Ravindra Prabhu2Karan Saraf3Postgraduate Student, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India.Assistant Professor (Selection grade), Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India.Professor and Head, Department of Nephrology, Kasturba Medical College, Manipal, Karnataka, India.Registrar, Department of Nephrology, Kasturba Medical College, Manipal, Karnataka, India.Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. FCM was the treatment of choice. This case report indicates the onset of adverse reaction with FCM with the second dose even though the first dose was well tolerated.http://jcdr.net/articles/PDF/10827/25908-CE(RA1)_F(GG)_PF1(PB_AP)_PFA(MJ_SS).pdfAnaemiaHypersensitivityIron preparations
collection DOAJ
language English
format Article
sources DOAJ
author Surabhi Sridhara
Rajesh Vilakkathala
Ravindra Prabhu
Karan Saraf
spellingShingle Surabhi Sridhara
Rajesh Vilakkathala
Ravindra Prabhu
Karan Saraf
Delayed Hypersensitivity with Ferric Carboxymaltose
Journal of Clinical and Diagnostic Research
Anaemia
Hypersensitivity
Iron preparations
author_facet Surabhi Sridhara
Rajesh Vilakkathala
Ravindra Prabhu
Karan Saraf
author_sort Surabhi Sridhara
title Delayed Hypersensitivity with Ferric Carboxymaltose
title_short Delayed Hypersensitivity with Ferric Carboxymaltose
title_full Delayed Hypersensitivity with Ferric Carboxymaltose
title_fullStr Delayed Hypersensitivity with Ferric Carboxymaltose
title_full_unstemmed Delayed Hypersensitivity with Ferric Carboxymaltose
title_sort delayed hypersensitivity with ferric carboxymaltose
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2017-11-01
description Ferric Carboxymaltose (FCM) is widely used in the treatment of anaemia of Chronic Kidney Disease (CKD). The clinicians must be alert of the rare adverse events such as hypersensitivity with subsequent doses of FCM. Here, we report a case of a 59-year-old male a known case of CKD, with anaemia and thrombocytopenia. FCM was the treatment of choice. This case report indicates the onset of adverse reaction with FCM with the second dose even though the first dose was well tolerated.
topic Anaemia
Hypersensitivity
Iron preparations
url http://jcdr.net/articles/PDF/10827/25908-CE(RA1)_F(GG)_PF1(PB_AP)_PFA(MJ_SS).pdf
work_keys_str_mv AT surabhisridhara delayedhypersensitivitywithferriccarboxymaltose
AT rajeshvilakkathala delayedhypersensitivitywithferriccarboxymaltose
AT ravindraprabhu delayedhypersensitivitywithferriccarboxymaltose
AT karansaraf delayedhypersensitivitywithferriccarboxymaltose
_version_ 1725364945585963008

Similar Items